Menu
Recruiting NCT05257434

Postoperative Outcomes in Patients With Hepato-biliary-pancreatic Cancer According to inBody Test

Observational Cancer

For patients and families

In plain language

An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.

What is being studied
The protocol lists: inbody.
Who it may be relevant to
Registry conditions: Cancer. Basic parameters: 18 years — 90 years · All.
What needs checking
Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
Where it takes place
Japan
Next step
Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →

Overview

postoperative outcomes were evaluated by using inBody test

Detailed description

postoperative outcomes were evaluated by using inBody test

Interventions

  • Behavioral inbody
    Body fluid composition

Primary outcome measures

  • long-term outcomes [Time frame: 5year]
Secondary outcome measures (1)
  • short-term outcomes [Time frame: up to 24 weeks]

Eligibility criteria

Inclusion criteria

  • surgically treated patients

Exclusion criteria

  • a body weight loss of >10% during the 6 months before surgery; the presence of distant metastases; or seriously impaired function of vital organs because of respiratory, renal, or heart disease

Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.

Healthy volunteers: No

Study design

Observational model
Cohort

Study locations

Japan · 1 center
  • Takehiro Okabayashi — Kochi

Publications

  • Kimura J, Sui K, Tabuchi M, Sakamoto S, Murokawa T, Iwata J, Morita S, Iiyama T, Okabayashi T. Preoperative percent body fat in bioelectrical impedance analysis predicts pancreatic fistula after pancreaticoduodenectomy. Langenbecks Arch Surg. 2023 Jun 28;408(1):248. doi: 10.1007/s00423-023-02998-y. PMID 37380749

Identifiers

NCT: NCT05257434 · Point study

Primary sources (government registries)

View this study on ClinicalTrials.gov ↗